Booz Allen Hamilton Inc.
Booz Allen Hamilton Inc. is a leading provider of management, technology, and engineering services to the U.S. government. It specializes in defense, intelligence, and civil markets, empowering organizations to transform through consulting, analytics, digital solutions, engineering, and cyber expertise.
Booz Allen Hamilton Inc. has an extensive history of providing a wide range of goods and services through prime and subcontract awards across various federal agencies. It has delivered cybersecurity solutions, IT modernization, program management support, data analytics, and systems engineering services to agencies such as the Department of Defense, Department of Veterans Affairs, Centers for Disease Control and Prevention, and the Air Force. Booz Allen Hamilton Inc. has received numerous contracts for technical assistance, engineering services, and professional services from the Department of the Navy, Department of the Army, Department of Energy, and the National Aeronautics and Space Administration (NASA). Many of these contracts did not have set-aside designations, and Booz Allen Hamilton Inc. has often collaborated with subcontractors like Peraton Inc., BAE Systems, and Salient CRGT Inc.
Through prime and subgrant awards, Booz Allen Hamilton Inc. has provided research and development services, data analysis, and technical assistance to federal agencies. For instance, it received a project grant from the Department of Commerce's National Telecommunications and Information Administration to advance the security of O-RAN enabled 5G radio access network systems, collaborating with Virginia Tech as a subrecipient. Booz Allen Hamilton Inc. has also been awarded subgrants to identify hazardous materials for system sustainment and safety, as well as to conduct data analysis and research related to health and substance use disorders.
Booz Allen Hamilton Inc. holds several federal contract indefinite delivery vehicles (IDVs) that streamline the procurement of professional services for various agencies. These include a $23 million NASA Blanket Purchase Agreement (BPA) for data analysis and technical support services, a $550 million indefinite delivery contract from the Department of Energy's Advanced Research Projects Agency-Energy for technical and administrative support services, and a $75 million multiple award IDIQ from the Department of Health and Human Services Administration for Community Living to provide program support, data analysis, and technical assistance. Additionally, Booz Allen Hamilton Inc. was awarded a $149 million BPA by the Food and Drug Administration for organizational change management and business modernization support services.
JCBMLGPE6Z71 541611
Not listed 8283 Greensboro Dr, McLean, VA 22102, USA
10/29/01 1/10/26 Deloitte Consulting LLP
Deloitte Consulting LLP, doing business as Deloitte, is a leading management and technology consulting firm that provides a wide range of professional services to the federal government through contract awards. As part of the larger Deloitte organization, it offers audit, consulting, tax, and advisory services to clients across various industries. For federal agencies, Deloitte delivers services such as IT modernization, data analytics, cybersecurity, program management, and organizational transformation. The company has extensive experience supporting numerous civilian and defense agencies, including the Departments of Health and Human Services, Veterans Affairs, Homeland Security, Treasury, and Defense.
Through prime and subcontract awards, Deloitte has provided diverse services to federal agencies. These include strategic planning and user design for the National Institutes of Health, enterprise measurement and configuration services for the Department of Veterans Affairs, and support for the IRS's Digitalization Program. Deloitte has also delivered data analytics and technical assistance for CDC's WISEWOMAN program, change management support for FEMA, and supply chain risk management services for the Department of Defense. The company often partners with small businesses and specialized firms as subcontractors, such as Goal Group LLC and Techop Solutions International, Inc. While Deloitte primarily competes for full and open contract opportunities, it has also supported small business prime contractors as a subcontractor on set-aside contracts.
Regarding federal grant awards, the provided information does not contain details about Deloitte Consulting LLP receiving prime federal grant awards. However, the company has participated as a subrecipient on at least one grant project. Deloitte was engaged by the Corporation for Public Broadcasting to provide administrative and technical assistance for the Next Generation Warning System Grant Program. This program aims to update public television and radio stations' equipment with the latest broadcast and alert technologies to deliver timely emergency warnings. Deloitte's role involves supporting the prudent administration of the grant program in compliance with federal requirements.
Deloitte Consulting LLP holds several significant federal contract Indefinite Delivery Vehicles (IDVs). These include a $60.7 billion multiple-award IDIQ contract under the VA's Transformation Twenty One Total Technology Next Generation Two (T4NG2) program, providing a wide range of IT services through 2033. The company also holds a $900 million Army Modernization Priorities Multiple Award Contract for research, development, and prototyping services. Additionally, Deloitte has been awarded Blanket Purchase Agreements (BPAs) by various agencies, including a $99 million BPA from the FDA for drug supply chain management services, a $136,551 BPA from TSA for enterprise support services, and a $15 million BPA from NASA for change management support. These IDVs allow Deloitte to compete for task orders across multiple federal agencies, providing services such as IT modernization, data analytics, cybersecurity, and management consulting.
CKV2L9GZKJK3 541611
Not listed 1919 N Lynn St, Arlington, VA 22209, USA
4/23/02 8/10/25 Westat, Inc.
Westat, Inc. is a prominent professional services firm that provides a wide range of research, technical assistance, and program support services to various federal agencies. Established in 1963 and headquartered in Rockville, Maryland, Westat specializes in survey research, data collection and analysis, program evaluation, and information technology solutions. The company has extensive experience working with government entities, particularly in areas such as public health, education, transportation, and social policy. Westat's federal contract and grant awards span numerous agencies, including the Department of Health and Human Services, Department of Education, National Science Foundation, and Department of Transportation, among others.
Through its federal contract awards, Westat has provided diverse services across multiple domains. For the National Cancer Institute, Westat has supported cancer clinical trials, offering services such as site study setup, protocol writing, and electronic patient-reported outcomes collection. The company has conducted national surveys for agencies like the National Highway Traffic Safety Administration, including occupant protection use surveys and booster seat usage studies. Westat has also provided data collection and analysis services for the Centers for Disease Control and Prevention, supporting programs such as the National Immunization Surveys. For the Food and Drug Administration, Westat has conducted studies on consumer perceptions of food labeling and medical device recalls. The company has also supported the Environmental Protection Agency with statistical analysis and technical support for various environmental health studies. These contracts demonstrate Westat's capabilities in large-scale data collection, analysis, and program evaluation across various public health and safety domains.
Westat's federal grant awards further showcase its expertise in research and evaluation services. The company has received grants from the National Institute of Justice to design and implement studies on interpersonal violence among young adults. For the National Institutes of Health, Westat has supported HIV/AIDS clinical trial networks and studies on maternal and child health. The company has also assisted the Bureau of Justice Statistics in conducting surveys on jails in Indian Country. Westat has collaborated with universities and research institutions on grants focused on topics such as sleep disparities, cognitive health, and substance abuse prevention. Additionally, the company has supported international health initiatives, such as population-based HIV impact assessment surveys in various countries. These grant-funded projects demonstrate Westat's ability to conduct complex, multi-year research studies and provide specialized data collection and analysis services in support of public health and social science research.
Westat holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, allowing for the issuance of task orders across a range of services. The company has a $320 million IDV with the National Cancer Institute for field and biospecimen support services, which includes study management, exposure assessment, and clinical support for cancer research. Westat also holds a $548 million IDV for the Cancer Trials Support Unit, providing broad-based support for cancer clinical trials. The Centers for Disease Control and Prevention awarded Westat a $310 million IDV for the National Immunization Surveys program, supporting vaccination coverage monitoring efforts. The company has a $175 million IDV with the National Institute of Child Health and Human Development for international and domestic pediatric HIV studies. Additionally, Westat holds IDVs with agencies such as the Substance Abuse and Mental Health Services Administration, the Administration for Community Living, and the Institute of Education Sciences, covering areas such as behavioral health research, aging and disability services, and education program evaluations. These IDVs demonstrate Westat's capacity to provide comprehensive, long-term support across various federal research and program evaluation initiatives.
NVUWAFWQ57S5 541720
Not listed 1600 Research Blvd, Rockville, MD 20850, USA
9/5/01 1/9/26 University Of North Carolina At Chapel Hill
The University of North Carolina at Chapel Hill (UNC-CH), doing business as Office of Sponsored Research, is a major public research university that receives substantial federal funding for research and development activities across a wide range of disciplines. As one of the oldest public universities in the United States, UNC-CH has extensive experience managing large-scale federally-funded projects. The university leverages its broad academic and research capabilities to provide services to federal agencies in areas such as biomedical research, public health, environmental science, social sciences, and technology development. UNC-CH's Office of Sponsored Research serves as the central administrative unit for managing federal awards and ensuring compliance with regulations.
Through federal contracts, UNC-CH has provided a variety of research, technical assistance, and professional services to agencies like the Department of Health and Human Services, Department of Defense, and Environmental Protection Agency. Recent contract work includes conducting clinical trials and health studies, providing bioinformatics and data analysis support, developing and testing medical countermeasures, and performing environmental assessments. For example, UNC-CH received a $270,047 contract from the EPA to analyze emissions reductions and air quality benefits from climate programs. The university also holds contracts to support military health research, such as a $1.5 million award from the Defense Health Agency to study testicular cancer survivorship. While most awards are full and open competition, UNC-CH has received some contracts set aside for educational institutions.
UNC-CH's federal grant portfolio spans an even broader range of research and programmatic activities. The university receives hundreds of millions in grant funding annually from the National Institutes of Health, National Science Foundation, and other agencies to conduct biomedical, clinical, and translational research on topics like cancer, infectious diseases, neuroscience, and genetics. Recent major grants include a $1.6 million award to study eating disorders genetics, $1.4 million to research racism's impact on Black parents of autistic children, and $775,000 to improve HIV care for adolescents in Kenya. UNC-CH frequently collaborates with other universities and research institutions as both a prime recipient and subrecipient on large multi-site studies and center grants. The university also receives grants for STEM education, workforce development, and community outreach programs.
UNC-CH holds an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases to provide pre-clinical research services for infectious disease studies. This $146.3 million single-award IDIQ runs through July 2031 and covers work in developing and refining animal models to evaluate potential vaccines, therapeutics, and diagnostics. Task areas include small animal models, non-human primate models, alternative models, and production of specialized reagents. This IDIQ supports NIAID's mission to advance medical countermeasures against emerging infectious diseases and antimicrobial resistance. As the sole awardee, UNC-CH is responsible for all contracted work under this vehicle, which may include services like efficacy studies, pathogen characterization, and reagent distribution to support NIAID's infectious disease research priorities.
D3LHU66KBLD5 611310
Not listed 104 Airport Dr #2200, Chapel Hill, NC 27599, USA
5/18/01 12/3/25 Emory University
Emory University, a private research institution in Atlanta, Georgia, is a major recipient of federal contract and grant awards through its Office of Sponsored Programs Division. As one of the nation's leading academic and research centers, Emory provides a wide range of services to the federal government, primarily in the areas of biomedical research, public health, and clinical studies. The university has an extensive track record of conducting federally funded research across various disciplines, including infectious diseases, cancer, neuroscience, and environmental health. Emory's expertise and resources make it a valuable partner for government agencies seeking to advance scientific knowledge and improve public health outcomes.
Through federal contract awards, Emory University has provided a diverse array of goods and services to government agencies. These include conducting clinical trials for new vaccines and therapeutics, developing diagnostic tools for infectious diseases, and performing advanced biomedical research. The university has received contracts from agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Department of Defense (DoD). Notable contract work includes studies on HIV/AIDS, influenza, and emerging infectious diseases. Emory has also been involved in contracts related to public health emergency preparedness and response, leveraging its expertise in epidemiology and infectious disease management. Many of these contracts are awarded directly to Emory as the prime contractor, though the university also frequently collaborates with other institutions and private sector partners as a subcontractor.
Emory University's federal grant portfolio is extensive and covers a wide range of research areas. The university receives substantial funding from various NIH institutes, including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Institute of Mental Health. These grants support cutting-edge research in areas such as HIV/AIDS, cancer biology, neurodegenerative diseases, and mental health disorders. Emory also receives grants from other federal agencies, including the National Science Foundation for basic science research and the Health Resources and Services Administration for healthcare workforce development. The university often serves as the prime recipient on these grants, leading large-scale research projects and clinical studies. Additionally, Emory frequently collaborates with other academic institutions, healthcare organizations, and community partners on grant-funded projects, serving as either the lead institution or a subrecipient.
Emory University holds a significant Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID) for the development and refinement of pre-clinical models of infectious diseases. This IDC, with a ceiling value of $146,300,000 and a performance period through July 2031, enables Emory to provide NIAID with the capability to develop, refine, and employ various animal models for studying infectious diseases. The contract covers work on small animal models, non-human primate models, animal replacement models, and non-traditional animal models. It also includes evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of candidate countermeasures such as therapeutics, vaccines, and diagnostics against a wide range of infectious agents, including those with pandemic potential and drug-resistant pathogens. This IDC positions Emory as a key partner in NIAID's efforts to advance the development of medical countermeasures against infectious diseases.
S352L5PJLMP8 611310
Not listed 201 Dowman Dr, Atlanta, GA 30322, USA
9/21/01 5/3/25